A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP TRIAL TO EVALUATE THE EFFECT OF THE AROMATASE INHIBITOR ANASTROZOLE ON THE PHARMACOKINETICS OF TAMOXIFEN (TAM) IN POSTMENOPAUSAL BREAST-CANCER PATIENTS
Js. Tobias et al., A RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP TRIAL TO EVALUATE THE EFFECT OF THE AROMATASE INHIBITOR ANASTROZOLE ON THE PHARMACOKINETICS OF TAMOXIFEN (TAM) IN POSTMENOPAUSAL BREAST-CANCER PATIENTS, European journal of cancer, 33, 1997, pp. 1127-1127